Skip to main content
SpringerLink
Log in
Book cover

Bladder Cancer pp 149–182Cite as

Pathologic Assessment of Bladder Cancer and Pitfalls in Staging

  • Chapter

  • 152 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

The classification of tumors of the bladder falls into three basic categories, histology, patterns of growth (e.g., papillary vs nonpapillary, invasive vs noninvasive), and malignancy grade. The histological tumor types primary to the urinary bladder epithelium are urothelial (transitional), squamous, glandular, and small cell. By far the most common histologic type is urothelial (transitional) (approximately 90%). The bulk of this discussion will therefore deal with this tumor type. However, as they comprise approximately 10% of primary bladder tumors a brief overview of some of the other tumor types is also indicated.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Johansson SL, Cohen SM. The pathology of bladder cancer. In: Bladder Cancer; Biology, Diagnosis and Management ( Syrigos KN, Skinner DG, eds.). Oxford University Press, 1999, pp. 97–123.

    Google Scholar 

  2. Bell JT, Burney SW, Friedell GH. Blood vessel invasions in human bladder cancer. J Urol 1971; 105: 675–678.

    CAS  PubMed  Google Scholar 

  3. Anderstrom C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 1980; 124: 23–26.

    CAS  PubMed  Google Scholar 

  4. Lopez JI, Angulo JC. The prognostic significance of vascular invasion in stage Tl bladder cancer. Histopathology 1995; 27: 27–33.

    CAS  PubMed  Google Scholar 

  5. Loening S, Narayana A, Yoder L, Slymen D, Weinstein S, Penick G, Culp D. Factors influencing the recurrence rate of bladder cancer. J Urol 1980; 123: 29–31.

    CAS  PubMed  Google Scholar 

  6. Heney NM, Prppe K Prout GR, Griffin PP, Shipley WU. Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 1983; 130: 895–897.

    CAS  PubMed  Google Scholar 

  7. Kern WH. The grade and pathologic stage of bladder cancer. Cancer 1984; 53: 1185–1189.

    CAS  PubMed  Google Scholar 

  8. Fossa SD, Reitan JB, Ous S, Odegaard A, Loeb M. Prediction of tumor progression in superficial bladder carcinoma. Eur Urol 1985; 11: 1–5.

    CAS  PubMed  Google Scholar 

  9. Malmström P-U, Lönnemark M, Busch C, Magnusson A. Staging of bladder carcinoma by computer tomography-guided transmural biopsy. Scand J Urol Nephrol 1993; 27: 193–198.

    PubMed  Google Scholar 

  10. Koss LG. Tumors of the urinary bladder. In: Atlas of Tumor Pathology Fascicle 11, AFIP. Bethesda, MD, 1975.

    Google Scholar 

  11. Murphy WM. Current topics in the pathology of bladder cancer. In: Pathology Annual, vol. 18 ( Sommers SC, Rosen PP, eds.). Appleton-Century-Crofts, Norwalk, CT, 1983, pp. 1–25.

    Google Scholar 

  12. Nagy GK, Frable WJ, Murphy WM. The classification of premalignant urothelial abnormalities: a Delphi study of the National Bladder Cancer Clinical Collaborative Group A. In: Pathology Annual, vol. 17 ( Sommers SC, Rosen PP, eds.). Appleton-Century-Crofts, Norwalk, CT, 1982, pp. 219–233.

    Google Scholar 

  13. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder and related structures. Third series Fascicle Armed Forces Institute of Pathology. Washington, DC, 1994.

    Google Scholar 

  14. Grignon D. Neoplasms of the urinary bladder. In: Urologic Surgical Pathology ( Bostwick DC, Eble JN, eds.). Mosby, New York, NY, 1997, pp. 184–302.

    Google Scholar 

  15. Newman DM, Brown JR, Jay AC, Pontius EE. Squamous cell carcinoma of the bladder. J Urol 1968; 100: 470–473.

    CAS  PubMed  Google Scholar 

  16. Rundle JSH, Hart AJL, McGeorge A, Smith JS, Malcolm AJ, Smith PM. Squamous cell carcinoma of the bladder. A review of 114 patients. Br J Urol 1982; 39: 522–526.

    Google Scholar 

  17. Johansson SL, Anderstrom CR. Primary adenocarcinoma of the urinary bladder and urachus. In: Textbook of Uncommon Cancer, 2nd ed (Raghaven D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Thigpen JT, eds.). Wiley, 1999, pp. 29–43.

    Google Scholar 

  18. Mostofi FK, Thompson RU, Dean AL Jr. Mucinous adenocarcinoma of the urinary bladder. Cancer 1955; 8: 741–758.

    CAS  PubMed  Google Scholar 

  19. Nocks BN, Heney NM, Daly JJ. Primary adenocarcinoma of urinary bladder. Urology 1983; 21 (1), 26–29.

    CAS  PubMed  Google Scholar 

  20. Mostofi FK. Pathological aspects and spread of carcinoma of the bladder. JAMA 1968; 206: 1764–1769.

    CAS  PubMed  Google Scholar 

  21. Anderstrom CR, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder, a clinical pathological prognostic study. Cancer 1983; 52: 1273 1279.

    Google Scholar 

  22. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG. Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer 1991; 67: 2165–2172.

    CAS  PubMed  Google Scholar 

  23. Davis BH, Ludwig ME, Cole SR, Pastuszak WT. Small cell neuroendocrine carcinoma of the urinary bladder: report of three cases with ultrstructural analaysis. Ultrastruct Pathol 1983; 4: 197–204.

    CAS  PubMed  Google Scholar 

  24. Holmang S, Borghede G, Johansson SL. Primary small cell carcinoma of the urinary bladder: a report of 25 cases. J Urol 1995; 153: 1820–1822

    CAS  PubMed  Google Scholar 

  25. Kim CK, Lin JI, Tseng CH. Small cell carcinoma of urinary bladder: ultrastructural study. Urology 1984; 24: 384–386.

    CAS  PubMed  Google Scholar 

  26. Podesta AH, True LC. Small cell carcinoma of the bladder: report of five cases with immunohistochemistry and review of the literature with evaluation of prognosis according to stage. Cancer 1989; 64: 710–714.

    CAS  PubMed  Google Scholar 

  27. Blomjous CE,Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder: a clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases Cancer 1989; 64: 1347–1357.

    Google Scholar 

  28. Hansemann D. Ueber asymmetrische Zelltheilung in Epithelkrebsen and deren biologische Bedeutung. Arch f Path Anat 1890; CXIX: 299–326.

    Google Scholar 

  29. Broders AC. Epithelioma of the genitourinary organs. Ann Surg 1922; 75: 574604.

    Google Scholar 

  30. Broders AC. Grading of cancer: its relationship to metastasis and prognosis. Texas State J Med 1933; 29: 520–525.

    Google Scholar 

  31. Geraghty JT. Treatment of malignant disease of the prostate and bladder. J Urol 1922; 7: 33–65.

    Google Scholar 

  32. Jewett HJ, Strong GH. Infiltrating carcinoma of the bladder. Relation of depth penetration of the bladder wall to incidence wall to incidence of local extension and metastases. J Urol 1946; 55: 366–372.

    CAS  PubMed  Google Scholar 

  33. Ash JE. Epithelial tumors of the bladder. J Urol 1940; 44: 135–145.

    Google Scholar 

  34. Bergkvist A, Ljungquist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 1965; 130: 371–378.

    CAS  PubMed  Google Scholar 

  35. Franksson C. Tumors of the urinary bladder. Acta Chir Scand 1950; 151 (Suppl): 1–203.

    CAS  Google Scholar 

  36. World Health Organization. Histological typing of urinary bladder tumours. International Histological Classification of Tumours. No 10. Geneva, 1973.

    Google Scholar 

  37. Malmström P-U, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21: 185–195.

    PubMed  Google Scholar 

  38. Epstein JI, Amin MB, Reuter VR, Mostofi FK, the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transistional Cell) Neoplasms of the Urinary Bladder. Am J Surg Path 1998; 22 (12): 1435–1448.

    PubMed  Google Scholar 

  39. World Health Organization. Histological typing of urinary bladder tumours. International Classification of Tumours. No 10. Second Edition. Geneva, 1999.

    Google Scholar 

  40. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson S. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162: 702–707.

    CAS  PubMed  Google Scholar 

  41. Johnson WD. Cytopathological correlations in tumors of the urinary bladder. Cancer 1964; 17: 867–880.

    CAS  PubMed  Google Scholar 

  42. Melamed MR, Koss LG, Ricci A, Whitmore WF. Cytohistological observations on developing carcinoma of the urinary bladder in man. Cancer 1960; 13: 67–74.

    CAS  Google Scholar 

  43. Esposti PL, Moberger G, Zajicek J. The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. A study of 567 cases of urinary-tract disorder including 170 untreated and 182 irradiated bladder tumors. ACTA Cytol 1970; 14: 145–155.

    CAS  PubMed  Google Scholar 

  44. Esposti PL, Zajicek J. Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings. ACTA Cytol 1972; 16 (6): 529–537.

    CAS  PubMed  Google Scholar 

  45. Herder A, Bjelkenkrantz K, Grontoft O. Histopathological subgrouping of WHO II urothelial neoplasms by cytophotometric measurements of nuclear atypia. Acta Path Microbiol Scand 1982; 90: 405–408.

    CAS  Google Scholar 

  46. Lipponen, PK, Eskelinen MJ, Kiviranta J, Nordling S. Classic prognostic factors, flow cytometric data, nuclear morpholmetric and mitotic indexes as predictors in transitional cell bladder cancer. Anticancer Res 1991; 11: 911–916.

    CAS  PubMed  Google Scholar 

  47. Nielson K, Petersen SE, Orntoft. A comparison between stereological estimates of mean nuclear volume and DNA flow cytometry in bladder tumours. APMIS 1989; 97: 949–956.

    Google Scholar 

  48. Ooms ECM, Kurver PHJ, Veldhuizen RW, Alons CL, Boon ME. Morphometric grading of bladder tumours in comparison with histologic grading by pathologists. Human Pathol 1982; 14 (2): 144–150.

    Google Scholar 

  49. Sowter C, Sowter G, Slavin G, Rosen D. Morphometry of bladder carcinoma: definition of a new variable. Anal Cell Pathol 1990; 2: 205–213.

    CAS  PubMed  Google Scholar 

  50. Schapers FM, Pauwels RPE, Wijnen JTM, Smeets WGB, Bosman FT. Morpho-metric grading of transitional cell carcinoma of the urinary bladder. J Urol Pathol 1995; 3: 107–118.

    Google Scholar 

  51. Choi HK, Vasko J, Bengtsson E, Jarkrans T, Malmstrom P-U, Wester K, Busch C. Grading of transtitional cell bladder carcinoma by texture analysis of histological sections. Anal Cell Pathol 1994; 6: 327–343.

    CAS  PubMed  Google Scholar 

  52. Choi HK, Jarkrans T, Bengtsson E, Vasko J, Wester K, Malmstrom P-U, Busch C. Image analysis based grading of bladder carcinoma. Comparison of object, textures and graph based methods and their reproducibility. Anal Cell Pathol 1997; 15: 1–18.

    CAS  PubMed  Google Scholar 

  53. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, et al. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 39823997.

    Google Scholar 

  54. Friedlander ML, Hedley D, Taylor I. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984; 37: 961–974.

    CAS  PubMed  Google Scholar 

  55. Loerum OD, Farsund T. Clinical application of flowcytometry; a review. Cytometry 1981; 2: 1–13.

    Google Scholar 

  56. Kirkhus B, Clausen OPF, Fjordvang H, Helander K, Iverson O, Reitan JB, Vaage S. Characterization of bladder tumours by multiparameter flow cytometry with special reference to grade II tumours. APMIS 1988; 96: 783–792.

    CAS  PubMed  Google Scholar 

  57. Farsund T, Hoestmark JG, Loerum OD. Relation between flow cytometric DNA distribution and pathology in human bladder cancer: a report on 69 cases. Cancer 1984; 54: 1771–1777.

    CAS  PubMed  Google Scholar 

  58. Fossa SD, Kaalhus O, Scott-Knudsen O. The clinical and histopathological significance of Feulgen DNA values in transitional cell carcinoma of the human urinary bladder. Eur J Cancer 1977; 13: 1155–1162.

    CAS  PubMed  Google Scholar 

  59. Hemstreet GP 3rd, West SS, Weems WL, Echols CK, McFarland S, Lewin J, Lindseth G. Quantitative fluorescence measurements of OA-stained normal and malignant bladder cells. Int J Cancer 1983; 31: 577–585.

    PubMed  Google Scholar 

  60. Tribukait BT, Gustafson H, Esposti P. Ploidy and proliferation in human bladder tumours as measured by flow cytometric DNA analysis and its relations to histopathology and cytology. Cancer 1979; 43: 1742–1751.

    CAS  PubMed  Google Scholar 

  61. Neuhaus M, Schmid U, Ackermann D, Zellweger T, Maurer R, Alund G, et al. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT 1 urinary bladder cancer. Hum Path 1999; 30 (1): 81–86.

    CAS  PubMed  Google Scholar 

  62. Junker K, Werner W, Mueller C, Ebert W, Schubert J, Claussen U. Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing. Int J Oncol 1999; 14 (2): 309–313.

    CAS  PubMed  Google Scholar 

  63. Sauter G, Gasser TC, Moch H, Richter J, Jiang F, Albrecht R, et al. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res 1997; 1 (Suppl): S37 - S43.

    Google Scholar 

  64. Zhang FF, Arber DA, Wilson TG, Kawachi MH, Slovak ML. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer:comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. Clin Cancer Res 1997; 3: 2317–2328.

    CAS  PubMed  Google Scholar 

  65. Helpap B, Köllermann J. Proliferative patterns of normal and dysplastic urothelium and papillary carcinoma. A contribution to the consensus classification of urothelial tumours of the urinary bladder. Hum Pathol (in press).

    Google Scholar 

  66. Vasko J, Malmström P-U, Taube A, Wester K, Busch C. Toward an objective method of mitotic figure counting and its prognostic significance in bladder cancer. J Urol Pathol 1995; 3: 315–326.

    Google Scholar 

  67. Wester K, Andersson A-C, Ranefall P, Bengtsson E, Malmstrom P-U, Busch C. Cultured human fibroblasts in agarose gel as a multifunctional control for immunohistochemistry. Standardization of Ki67 (MIB1) assessment in routinely processed tissues. J Pathol (in press).

    Google Scholar 

  68. Tsutsumi M, Sugano K, Yamaguchi K, Kakizoe T, Akaza H. Correlation of allelic loss of the p53 gene and tumor grade, stage, and malignant progression in bladder cancer. Int J Urol 1997; 4: 74–78.

    CAS  PubMed  Google Scholar 

  69. Cordon-Cardo C, Zhang Z-F, Dalbagni G, Drobnjak M, Charytonowicz E, Hu S-X, et al. Cooperative effects of p53 and pRb alterations in primary superficial bladder tumors. Cancer Res 1997; 57: 1217–1221.

    CAS  PubMed  Google Scholar 

  70. Hermann G, Horn T, Steven K. The influence on the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in Stage I bladder cancer. J Urol 1998; 159: 91–94.

    CAS  PubMed  Google Scholar 

  71. Lianes P, Orlow I, Zhang Z-F, Oliva MR, Reuter VE, Cordon-Cardo C. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst 1994; 86 (17): 1325–1330.

    CAS  PubMed  Google Scholar 

  72. King ED, Matteson J, Jacobs SC, Kyprianou N. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 1996; 155: 316–320.

    CAS  PubMed  Google Scholar 

  73. Esrig D, Elmajian D, Freeman JA, Stein JP, Chen S-C, Nichols PW, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994; 331: 1259.

    CAS  PubMed  Google Scholar 

  74. Malmström P-U, Wester K, Vasko J, Busch C. Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods. APMIS 1992; 100: 988–992.

    PubMed  Google Scholar 

  75. Cote RJ, Esrig D, Groshen S, Jones PA, Skinner DG. p53 and treatment of bladder cancer. Nature 1997; 385: 123–124.

    CAS  PubMed  Google Scholar 

  76. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 1992; 52: 1393–1398.

    CAS  PubMed  Google Scholar 

  77. Uchida T, Wada C, Ishida H, Wang C, Egawa S,Yokoyama E, et al. p53 mutations and prognosis in bladder tumors. J Urol 1995; 153: 1097–1104.

    CAS  PubMed  Google Scholar 

  78. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784–788.

    CAS  PubMed  Google Scholar 

  79. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/ CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391.

    CAS  PubMed  Google Scholar 

  80. Bond JA, Blaydes JP, Rowson J, Haughton MF, Smith JR, Wynford-Thomas D, Wyllie FS. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI I TWAF1. Cancer Res 1995; 55: 2404.

    Google Scholar 

  81. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, et al. p53-independent expression of p21 Cipl in muscle and other terminally differentiating cells. Science 1995; 267: 1024.

    CAS  PubMed  Google Scholar 

  82. Stein JP, Ginsberg DA, Grossfeld GD, Esrig D, Freeman JA, Dickenson MG, et al. The effect of p21 expression on tumor progression in p53 altered bladder cancer. J Urol 1996; 155(Part 2): 628A, abstract 1270.

    Google Scholar 

  83. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992; 84: 1251–1256.

    CAS  PubMed  Google Scholar 

  84. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992; 84: 1256–1261.

    CAS  PubMed  Google Scholar 

  85. Cote RJ, Dunn MD, Chatterjee SJ, Stein S-R, et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 1998; 58: 1090–1094.

    CAS  PubMed  Google Scholar 

  86. Cote RJ, Chatterjee J. Molecular determinants of outcome in bladder cancer. Cancer J 1999; 5 (1): 2–15.

    CAS  Google Scholar 

  87. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications of human neoplasia. Am J Pathol 1995; 147: 545.

    CAS  PubMed  Google Scholar 

  88. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, et al. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol 1998; 160: 645–659.

    CAS  PubMed  Google Scholar 

  89. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen S-C, Skinner DG, Nichols PW. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87 (21): 1603–1612.

    CAS  PubMed  Google Scholar 

  90. Neal DE, Sharples L, Smith K, Fennel J, Reg R, Hall MS, Harris AL. The epidermal growth factor receptor in the prognosis of bladder cancer. Cancer 1990; 65: 1619–1625.

    CAS  PubMed  Google Scholar 

  91. Messing EM. Clinical implications and the expression of the epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 1990; 50: 2530 2534.

    Google Scholar 

  92. Wood DP, Fair WR, Chatanti RSK. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J Urol 1992; 147: 274–277.

    PubMed  Google Scholar 

  93. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Zhang G, Singleton TP, et al. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol 1994; 101: 166–176.

    CAS  PubMed  Google Scholar 

  94. Marshall VF. The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasm. J Urol 1952; 68: 714–723.

    CAS  PubMed  Google Scholar 

  95. UICC International Union Against Cancer. In: TNM Classification of Malignant Tumours 4th ed. (Hermanek P, Sobin LH, eds.). Springer-Verlag, Berlin, 1998, pp. 135–137.

    Google Scholar 

  96. AJCC. Cancer Staging Manual, Fifth Ed. Lippincott-Raven, Philadelphia, New York, 1997.

    Google Scholar 

  97. Pearse HD, Reed RR, Hodges CV. Radical cystectomy for bladder cancer. J Urol 1978; 119: 216–218.

    CAS  PubMed  Google Scholar 

  98. Blandy JP, England HR, Evans JW, Hope-Stone HF, Mair GMN, Mantell Beth Shearon, MD, et al. T3 bladder cancer-the case for salvage cystectomy. Br J Urol 1980; 52: 506–510.

    CAS  PubMed  Google Scholar 

  99. Hall RR, Prout GR. Staging of bladder cancer. Is tumor, node, metastases system adequate? Semin Oncol 1990; 17: 517–23.

    CAS  PubMed  Google Scholar 

  100. Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages TA and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995; 153: 1823–1827.

    PubMed  Google Scholar 

  101. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR, for National Bladder Cancer Collaborative Group A. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083–1086.

    PubMed  Google Scholar 

  102. Melicow MM, Hollowell, Wisecarver J. Intra-urothelial cancer: carcinoma in situ, Bowen’s disease of the urinary system: discussion of thirty cases. J Urol 1952; 68: 763–772.

    CAS  Google Scholar 

  103. Schellhammer PF, Bean MA, Whitmore Jr WF. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977; 118: 399–403.

    CAS  PubMed  Google Scholar 

  104. Wood DP Jr, Montie JE, Pontes JE, Vanderbrug Medendorp S, Levin HS. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed fro bladder cancer. J Urol 1989; 141: 346–349.

    PubMed  Google Scholar 

  105. Hardeman SW, Soloway MS. Transitional cell carcinoma of the prostate: diagnosis, stageing and management. World J Urol 1988; 6: 170–174.

    Google Scholar 

  106. Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen S-C, Groshen S, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156: 1071–1076.

    CAS  PubMed  Google Scholar 

  107. Pagano F, Bassi P, Ferrante GLD, Piazza N, Abatangelo G, Pappagallo GL, Garbeglio A. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155: 244–247.

    CAS  PubMed  Google Scholar 

  108. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat 1983; 136: 265–271.

    CAS  PubMed  Google Scholar 

  109. Ro JY, Ayala AG, El-Naggar A. Muscularis mucosa of urinary bladder-importance for staging and treatment. Am J Surg Pathol 1987; 11 (9): 668–673.

    CAS  PubMed  Google Scholar 

  110. Keep TC, Piehl M, Miller A, Oyasu R. Invasive carcinomas of the urinary bladder-evaluation of tunica muscularis mucosae involvement. AJCP 1988; 9: 575–579.

    Google Scholar 

  111. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990; 66: 543–548.

    CAS  PubMed  Google Scholar 

  112. Hasui Y, Osada Y, Kitada S, Nishi S. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994; 43: 78 2786.

    Google Scholar 

  113. Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995; 45: 47–53.

    CAS  PubMed  Google Scholar 

  114. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800–804.

    CAS  PubMed  Google Scholar 

  115. Smits G, Schaafma E, Kiemeney L, Christen C, Debruyne F, Witjes JA. Micro-staging of pTl transitional cell carcinoma of the bladder. Identification of subgroups with distinct risks of progression. Urology 1998; 52: 1009–1015.

    CAS  PubMed  Google Scholar 

  116. Platz CE, Cohen MB, Jones MP, Olson DB, Lynch CF. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod Pathol 1996; 9: 1035–1039.

    CAS  PubMed  Google Scholar 

  117. Larsen MP, Steinberg GD, Brendler CB, Epstein JI. Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and pseudovascular invasion in transitional cell carcinoma. Mod Pathol 1990; 3: 83–88.

    CAS  PubMed  Google Scholar 

  118. Ramani P, Birch BRP, Harland SJ, Parkinson MC. Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pTl transitional carcinoma of the bladder. Histopathology 1991; 19: 551–554.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Christer Busch MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debra Hawes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonny L. Johansson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard J. Cote MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Mount Sinai School of Medicine, New York, NY, USA

    Michael J. Droller MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Busch, C., Hawes, D., Johansson, S.L., Cote, R.J. (2001). Pathologic Assessment of Bladder Cancer and Pitfalls in Staging. In: Droller, M.J. (eds) Bladder Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-097-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-097-1_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-202-5

  • Online ISBN: 978-1-59259-097-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation